Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|April 21, 2010
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolatesLouis Saravolatz, Joan Pawlak, Leonard Johnson
The American Journal of the Medical Sciences|March 14, 2022
Clinical predictors and outcomes for Legionnaire's disease versus bacteremic pneumococcal pneumoniaSima Salahie, Susan Szpunar, Louis Saravolatz
The American Journal of the Medical Sciences|May 4, 2025
The prognostic nutritional index as a risk factor for severe COVID-19 infection among hospitalized patients: A multicenter historical cohort studyAshish Bhargava, Susan Szpunar, Louis Saravolatz
Journal of Cardiology Cases|December 12, 2018
Intermittent AV block conduction abnormalities in the setting of acute pancreatitisCarol Chen-Scarabelli, Louis Saravolatz, Tiziano M Scarabelli
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|March 28, 2024
Using the Electronic Medical Record to Address Code Status Documentation: A Quality Improvement ProjectJohn Sorge, Susan Szpunar, Theodore Daniel, et al.
International Journal of Antimicrobial Agents|June 14, 2005
Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniaeLouis Saravolatz, Odette Manzor, Joan Pawlak, et al.
Viruses|June 27, 2025
Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: "Symptom Rebound"Ashish Bhargava, Susan Szpunar, Mamta Sharma, et al.
Cureus|May 24, 2023
Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based StudyTalal Bazzi, Muneer Al-Husseini, Louis Saravolatz, et al.
Microorganisms|March 27, 2025
<i>Candida auris</i>: A Continuing ThreatAshish Bhargava, Katherine Klamer, Mamta Sharma, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registryChatchawan Piyaskulkaew, Tejwant Singh, Susan Szpunar, et al.
Pageof 6